The Autonomic Nervous System (ANS) is the major part of the nervous system that regulates and manages processes of the internal organs, including the blood vessels, stomach, intestine, liver, kidneys, bladder, genitals, lungs, pupils, heart, and sweat, salivary, and digestive glands. Autonomic testing is an umbrella term that covers testing of the two main divisions of the nervous system, which are the parasympathetic and sympathetic (P&S) nervous system. The P&S nervous systems regulate physiologic processes, such as blood pressure, heart rate, body temperature, digestion, metabolism, fluid and electrolyte balance, sweating, urination, defecation, sexual response, and other processes. This regulation occurs without conscious control, i.e., autonomously and it extends to every organ system in the body. In fact, many organ specific tests are tests of autonomic function.

TMCAMS technology provides the only commercially available means to independently and simultaneously test the P&S nervous systems. P&S testing is an integral component of the clinical evaluation of patients with autonomic disorders. Most drugs and diseases affect only one of the two autonomic branches. P&S monitoring quantifies the individual patient’s responses to disease and therapy. Quantitative data, enables a more scientific approach to individualized healthcare, potentially reducing medication-load, hospitalization, and re-hospitalization, and promoting preventative, pro-active healthcare, thereby reducing healthcare costs both to patients and to the nation. Autonomic testing is an established subspecialty recognized by the United Council on Neurologic Subspecialties (UCNS), which certifies physicians and laboratories with training and expertise in this discipline.

Current data, which has been accumulated through scientific research and clinical experience and published in peer-reviewed journals over the past 30 years, have defined the role of P&S testing in the diagnosis and management of autonomic disorders in clinical practice. It has established the value of P&S testing in the longitudinal study of disease.

TMCAMS technology has a unique and patent-protected technology position in P&S nervous system function monitoring. This is based on an initial MIT patent license and several follow-on patents held by ANSAR’s management which is recognized as a leader in the autonomic nervous system function monitoring field.

Its well-designed and proven product has been market validated having obtained a large customer base of active professional users including cardiologists, endocrinologists, Family Practitioners, Gastrointestinal Specialists, General Practitioners, Internal Medicine Practitioners, Neurologists, Pain Management Specialists, Pulmonologists, and Sleep Medicine Specialists.

TMCAMS can deliver a comprehensive telehealth solution that can be used by patients with support of health professionals to provide quality real-time remote clinical patient data. The TeleMedCare health monitor can be configured to allow patients to take a range of clinical measurements in their own home. This is ideal for health care professionals requiring comprehensive health data necessary to monitor patient status, progress, and medical decisions. As well as the convenience to provide remote patient care. TMCAMS technology is simple for patients to use and highly cost effective since it is the only device required for collecting the wide scope of data required by most healthcare professionals.

TMCAMS technology is simple for patients to use and highly cost effective since it is the only device required for collecting the wide scope of data required by most healthcare professionals